SCHEMBL5449477

SCHEMBL5449477

N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)cc2NS(N)(=O)=O)n2ccnc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 20/20 0.76
STS P08842 5/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5444323 0.82 CYP19A1 (0.77) CYP19A1STS
SCHEMBL15061442 0.82 CYP19A1 (0.77) CYP19A1STS
SCHEMBL5449359 0.81 CYP19A1 (0.71) CYP19A1STS
SCHEMBL6240994 0.80 CYP19A1 (0.73) CYP19A1STS
SCHEMBL5453075 0.78 CYP19A1 (0.77) CYP19A1STS
SCHEMBL5443729 0.78 CYP19A1 (0.67) CYP19A1STS
SCHEMBL5447469 0.74 CYP19A1 (0.67) CYP19A1STS
SCHEMBL5447513 0.74 CYP19A1 (0.79) CYP19A1STS
SCHEMBL5439291 0.74 CYP19A1 (0.79) CYP19A1STS
Hydrochloric Acid SCHEMBL15061457 0.73 CYP19A1 (0.78) CYP19A1STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US claimed
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CYP19A1 761/4885STS 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.